Clinical Trial Update: SurgiMend in Two-stage Implant-based Breast Reconstruction in Patients With Pre-Mastectomy Radiotherapy [NA]

View source ↗

Summary

A clinical trial evaluating SurgiMend for two-stage implant-based breast reconstruction in patients who had pre-mastectomy radiotherapy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• SurgiMend

Snippet

Sponsor: Integra LifeSciences Corporation | Conditions: Breast Cancer | NA | Status: WITHDRAWN